WFSBP guidelines on how to grade treatment evidence for clinical guideline development
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
OBJECTIVE AND METHODS: This paper reviews sources of data typically used in guideline development, available grading systems, their pros and cons, and the methods for evaluating risks of bias in publications, and proposes a revised method for grading evidence and recommendations for use in development of clinical treatment guidelines. RESULTS: The new World Federation of Societies of Biological Psychiatry (WFSBP) grading system allows guideline developers to follow a multi-step approach of defining levels of evidence, applying criteria for grading (define the acceptability) and the grading of recommendations. CONCLUSIONS: Further, these updated WFSBP recommendations for rating evidence and treatment recommendations provide a grading system that takes into account potential biases in sources of evidence in arriving at final ratings that are likely more clinically meaningful and pragmatic and thus should be used for the development of future treatment guidelines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
The well-built clinical question: A key to evidence-based decisions
(1995) · ACP Journal Club · doi:10.7326/acpjc-1995-123-3-a12 · Cited by 2,931 · cited 2×
“Build recommendations based on the PICO (patient/population, intervention, comparison, outcome) clinical question scheme (Richardson et al. 1995) taking into account bullet points 6 and 7 defined above (for example: ‘For patients with”
MethodROBIS: A new tool to assess risk of bias in systematic reviews was developed
Whiting, P., Savović, J., Higgins, J. P. T., Caldwell, D. M., Reeves, B. C., Shea, B., Davies, P., Kleijnen, J., & Churchill, R. (2016) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2015.06.005 · Cited by 2,272 · cited 3×
“…and/or adapt high-grade guidelines after methodological evaluation and/or use recent metaanalyses/systematic reviews after methodological evaluation (e.g., AMSTAR, ROBIS) (Shea et al. 2009; Whiting et al. 2016; Shea et al. 2017) to provide a comprehensive overview of the available evidence.”
Shea, B. J., Hamel, C., Wells, G. A., Bouter, L. M., Kristjansson, E., Grimshaw, J., Henry, D. A., & Boers, M. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2008.10.009 · Cited by 1,755 · cited 3×
“…and/or adapt high-grade guidelines after methodological evaluation and/or use recent metaanalyses/systematic reviews after methodological evaluation (e.g., AMSTAR, ROBIS) (Shea et al. 2009; Whiting et al. 2016; Shea et al. 2017) to provide a comprehensive overview of the available evidence.”
MethodEfficacy of treatments for anxiety disorders: a meta-analysis
Bandelow, B., Reitt, M., Röver, C., Michaelis, S., Görlich, Y., & Wedekind, D. (2015) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000078 · Cited by 555 · cited 6×
“…studies for anxiety disorders, it was shown that large effect size differences exist between various drugs and that medication was more effective than psychotherapy, a result which would not have been found when only looking at the few available head-tohead comparisons (Bandelow et al. 2015).”
BackgroundInfluentialSelf-citationMeta-analysis: Its strengths and limitations
WALKER, E., HERNANDEZ, A. V., & KATTAN, M. W. (2008) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.75.6.431 · Cited by 519 · cited 1×
“Meta-analyses have specific advantages (Fagard et al. 1996; Walker et al. 2008; Stone and Rosopa 2017): The results of studies using different scales can be easily compared If conflicting results exist with one treatment, i.e., some studies show superiority to placebo and others not, meta-analyses…”
ResultOwens, D. K., Lohr, K. N., Atkins, D., Treadwell, J. R., Reston, J. T., Bass, E. B., Chang, S., & Helfand, M. (2010) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.03.009 · Cited by 513
Grading the strength of a body of evidence when assessing health care interventions: an EPC update
Berkman, N. D., Lohr, K. N., Ansari, M. T., Balk, E. M., Kane, R., McDonagh, M., Morton, S. C., Viswanathan, M., Bass, E. B., Butler, M., et al. (2015) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2014.11.023 · Cited by 279 · cited 13×
“Develop a system that allows to up- or downgrade recommendations based on the criteria for grading recommendations detailed below as suggested by AWMF (AWMF 2012) and GRADE (Berkman et al. 2015; GRADE 2017).”
BackgroundMethodInfluentialp-Curve and p-Hacking in Observational Research
Bruns, S. B., & Ioannidis, J. P. A. (2016) · PLOS ONE · doi:10.1371/journal.pone.0149144 · Cited by 210
McGirr, A., Vöhringer, P. A., Ghaemi, S. N., Lam, R. W., & Yatham, L. N. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30264-4 · Cited by 149
Self-citation
Cited by
Bandelow, B., Allgulander, C., Baldwin, D. S., Costa, D. L. D. C., Denys, D., Dilbaz, N., Domschke, K., Eriksson, E., Fineberg, N. A., Hättenschwiler, J., et al. (2023) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2022.2086295 · Cited by 158
Self-citationTurner, D., Briken, P., Grubbs, J., Malandain, L., Mestre-Bach, G., Potenza, M. N., & Thibaut, F. (2022) · Dialogues in Clinical Neuroscience · doi:10.1080/19585969.2022.2134739 · Cited by 86
Pharmacological Augmentation in Unipolar Depression: A Guide to the Guidelines
Taylor, R. W., Marwood, L., Oprea, E., DeAngel, V., Mather, S., Valentini, B., Zahn, R., Young, A. H., & Cleare, A. J. (2020) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaa033 · Cited by 76
“…the use of a consistent evidence grading system such as the recent WFSBP guidelines on how to grade treatment evidence for guideline development (Hasan et al., 2019), may improve the overall quality of treatment guidelines and support greater alignment between future recommendations…”
MethodKinney, C., Saville, P., Heiderscheit, A., & Himmerich, H. (2025) · Behavioral Sciences · doi:10.3390/bs15020138 · Cited by 28
“According to the best-practice guidelines by the World Federation of Societies of Biological Psychiatry (Hasan et al., 2019), a minimum of two positive RCTs are required before a treatment can be recommended with confidence.”
Pharmakotherapie der Essstörungen—Ein Update
Bauman, T., & Voderholzer, U. (2025) · Der Nervenarzt · doi:10.1007/s00115-025-01804-y · Cited by 4
Metadata
- Authors
- Hasan, A., Bandelow, B., Yatham, L. N., Berk, M., Falkai, P., Möller, H.-J., Kasper, S., & WFSBP Guideline Task Force Chairs
- Venue
- The World Journal of Biological Psychiatry
- Publisher
- Informa UK Limited
- Published
- 2019-01-02
- Volume
- 20
- Issue
- 1
- Pages
- 2-16
- ISSN
- 1562-2975 (ISSN-L)
- 1814-1412
- OpenAlex
- W2904205814
- Cited by
- 44
- References
- 13
- FWCI
- 2.64
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: WFSBP guidelines on how to grade treatment evidence for clinical guideline development. https://app.cochat.ai/papers/10.1080/15622975.2018.1557346
- The paper
- Hasan, A., Bandelow, B., Yatham, L. N., Berk, M., Falkai, P., Möller, H.-J., Kasper, S., & WFSBP Guideline Task Force Chairs. (2019). WFSBP guidelines on how to grade treatment evidence for clinical guideline development. The World Journal of Biological Psychiatry. https://doi.org/10.1080/15622975.2018.1557346
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.